Abstract:Objective To investigate the effects of radiosensitivity enhancement and inhibition of migration ability of human lung adenocarcinoma cells by celecoxib,a selective cyclooxygenase (COX)-2 inhibitor.Methods Human lung adenocarcinoma cells of the line A549 were cultured and then inoculated into six-well plates and randomly divided into 4 groups:control group,celecoxib group administered with celecoxib at the subtoxic doses 30 and 50 μmol/L,irradiated group exposed to 0,1,2,4,6,or 8 Gy by linear accelerator,and combined treatment (celecoxib + irradiation) group.The radiosensitizing effect of celecoxib was assessed by clonogenic cell survival test.The migration ability of the A549 cells was measured by scratch-wound test and the content of metalloproteinase-2 (MMP-2) in culture supernatant was detected with ELISA.Results The sensitization enhancement ratio of the celexib group was increased dosedependently.The values of D0 ,Dq,SF2 and D0.01 of the celecoxib + irradiation group were all significantly lower than those of the irradiated group.Scratch-wound test showed that the no-scratch area of the celecoxib + irradiation group and celecoxib group were all significantly wider than those of the mere irradiation and control groups and there was a dose-dependent manner,and the no-scratch area of the celecoxib + irradiation group was wlider than that of the celecoxib group.ELISA showed that the MMP-2 levels in the supernatant of the celecoxib group and celecoxib + irradiation group were respectively significantly lower than those of the control group and mere irradiated group (t = 3.78,5.79、3.15,P ＜ 0.05),however,there was not significant difference between the mere irradiation and control groups (t = 2.73,2.38,P ＞ 0.05).Conclusions Celecoxib enhances concentration-dependently the radiosensitivity of human lung carcinoma cell and inhibits the secretion of MMP-2 of the carcinoma cells,thus inhibiting their migration ability.

Enhancement of Radiation Sensitivity by Erlotinib and Celecoxib in A549 Human Lung Cancer Cell Line

Celecoxib-erlotinib combination treatment enhances radiosensitivity in A549 human lung cancer cell.

Icotinib Hydrochloride Enhances Chemo- And Radiosensitivity By Inhibiting Egfr Signaling And Attenuating Rad51 Expression And Function In Hela S3 Cells

Celecoxib and Afatinib Synergistic Enhance Radiotherapy Sensitivity on Human Non-Small Cell Lung Cancer A549 Cells

Radiosensitizing effects of cyclooxygenase-2 selective inhibitor LM-1685 on A549 human lung adenocarcinoma cells

Celecoxib Enhances the Sensitivity of Non-Small-cell Lung Cancer Cells to Radiation-Induced Apoptosis Through Downregulation of the Akt/mTOR Signaling Pathway and COX-2 Expression

Celecoxib's Radiosensitizing Effects on Three Different Human Cancer Cell Lines

Synergistic Effects of TOR Combined with EADM on Growth and Apoptosis in Human Lung Cancer Cell Lines A549 and H1299

Radiosensitization of Celecoxib on Human Lung Adenocarcinoma Cell Line A549 and Inhibition of Migration Ability in Vitro

Celecoxib Enhances Radiosensitivity Via Induction of G2-M Phase Arrest and Apoptosis in Nasopharyngeal Carcinoma

Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study

Inhibition of Cyclooxygenase‑2 Sensitizes Lung Cancer Cells to Radiation‑induced Apoptosis

Effect of Taxotere Combination with Celecoxib on Proliferation of NSCLC Cell

Study of the mechanism of radiation sensitizing effect of celecoxib on breast cancer cells with different estrogen receptors status

The Depressive Effect of Detected on the Proliferation of A549 Human Lung Adenocarcinoma Cell Lines and Celecoxib Combined with Cisplatin or X-ray

Radiosensitizing Effects of COX-2 Inhibitor Celecoxib on the Five Different Human Malignent Cell Lines

Experimental study on the regulation of erlotinib-induced radiosensitization with an anti-c-MET monoclonal antibody

Radiosensitizing Effect of Celecoxib on Human Pancreatic Carcinoma

Inhibition of Both EGFR and IGF1R Sensitized Prostate Cancer Cells to Radiation by Synergistic Suppression of DNA Homologous Recombination Repair

The Different Radiosensitivity when Combining Erlotinib with Radiation at Different Administration Schedules Might Be Related to Activity Variations in C-Met-pi3k-akt Signal Transduction.

Synergistic inhibitory effect of erlotinib and celecoxib on the growth of cholangiocarcinoma cells